A Discussion with Mark White Investment Director Rainbow Seed Fund
Mark White, BA, MBA, is Midven’s investment director and is an investment committee member...
read more
On 11 October in London, Rainbow Seed Fund Investment Director Oliver Sexton will be speaking at the Innovation Forum’s Innovation in Synthetic Biology conference.
The event joins leading synthetic biology experts from academia and industry with entrepreneurs, investors and policymakers to review the current environment and explore future trends in the field. Oliver will speak on the Executive Panel with Dr. Stephen Chambers, CEO of Bio-Start competition partner SynbiCITE, and Professor Richard Kitney, OBE – EPSRC National Centre for Synthetic Biology and Innovation. As the field of synthetic biology becomes more and more attractive to entrepreneurs, innovators and technologists, the panel will discuss the global trends and challenges when raising funding and how future innovations can mitigate risks and become more agile.
For more details on Innovation Forum’s event, please visit http://ucl.inno-forum.org/event/innovation-in-synthetic-biology/.
Mark White, BA, MBA, is Midven’s investment director and is an investment committee member...
read moreCRISPR-Cas9 is a precise and targeted technique for genome editing that allows even a...
read more